Characterization of polarized expression of point- or deletion-mutated human BCRP/ABCG2 in LLC-PK1 cells

被引:43
作者
Takada, T
Suzuki, H
Sugiyama, Y [1 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
[2] Tokyo Univ Hosp, Fac Med, Dept Pharm, Bunkyo Ku, Tokyo 113, Japan
关键词
breast cancer resistance protein; epithelial cells; transporter;
D O I
10.1007/s11095-004-1884-9
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. In polarized cells, such as hepatocytes and intestinal epithelial cells, transporters are localized on the apical or basolateral membranes and play important roles in the vectorial transport of their substrates. In the current study, we have aimed to clarify the mechanism for the cellular sorting of human breast cancer resistance protein (BCRP/ABCG2), which is expressed on the apical membrane of many tissues and functions as an efflux transporter. Methods. After the expression vector, including wild type or mutants of human BCRP cDNA, was transfected into LLC-PK1 cells, immunohistochemical staining and Western blot analyses were performed to characterize the cellular localization and the status of BCRP, respectively. Results. The transfected cDNA product of wild-type BCRP was expressed on the apical membrane in LLC-PK1 cells. Glycosylation consensus sequences-disrupted mutants showed the apical localization as the wild type, whereas the apical-selective expression disappeared when disulfide bonds could not be formed. Furthermore, examination of the localization of deletion mutants of human BCRP emphasized the importance of some peptide sequences. The region between the N-terminal and ATP-binding cassette and proximal C-terminal region, both of which are well conserved in various animal species, were found to be significant for proper localization. Conclusions. These results suggest that, although the presence of N-glycan does not affect the localization of BCRP, disulfide bonds and some peptide sequences in both the N- and C-terminals are necessary for the apical expression of BCRP.
引用
收藏
页码:458 / 464
页数:7
相关论文
共 34 条
[1]  
Allikmets R, 1998, CANCER RES, V58, P5337
[2]   Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) [J].
Doyle, LA ;
Ross, DD .
ONCOGENE, 2003, 22 (47) :7340-7358
[3]   A multidrug resistance transporter from human MCF-7 breast cancer cells [J].
Doyle, LA ;
Yang, WD ;
Abruzzo, LV ;
Krogmann, T ;
Gao, YM ;
Rishi, AK ;
Ross, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15665-15670
[4]   Isoforms of the lutheran/basal cell adhesion molecule glycoprotein are differentially delivered in polarized epithelial cells - Mapping of the basolateral sorting signal to a cytoplasmic di-leucine motif [J].
El Nemer, W ;
Colin, Y ;
Bauvy, C ;
Codogno, P ;
Fraser, RH ;
Cartron, JP ;
Le van Kim, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) :31903-31908
[5]   A novel clathrin adaptor complex mediates basolateral targeting in polarized epithelial cells [J].
Fölsch, H ;
Ohno, H ;
Bonifacino, JS ;
Mellman, I .
CELL, 1999, 99 (02) :189-198
[6]   Identification of the apical membrane-targeting signal of the multidrug resistance-associated protein 2 (MRP2/cMOAT) [J].
Harris, MJ ;
Kuwano, M ;
Webb, M ;
Board, PG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :20876-20881
[7]   C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins [J].
Hegedüs, T ;
Sessler, T ;
Scott, R ;
Thelin, W ;
Bakos, É ;
Váradi, A ;
Szabó, K ;
Homolya, L ;
Milgram, SL ;
Sarkadi, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (03) :454-461
[8]   Breast cancer resistance protein exports sulfated estrogens but not free estrogens [J].
Imai, Y ;
Asada, S ;
Tsukahara, S ;
Ishikawa, E ;
Tsuruo, T ;
Sugimoto, Y .
MOLECULAR PHARMACOLOGY, 2003, 64 (03) :610-618
[9]   The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria [J].
Jonker, JW ;
Buitelaar, M ;
Wagenaar, E ;
van der Valk, MA ;
Scheffer, GL ;
Scheper, RJ ;
Plösch, T ;
Kuipers, F ;
Elferink, RPJO ;
Rosing, H ;
Beijnen, JH ;
Schinkel, AH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15649-15654
[10]   Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization [J].
Kage, K ;
Tsukahara, S ;
Sugiyama, T ;
Asada, S ;
Ishikawa, E ;
Tsuruo, T ;
Sugimoto, Y .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (05) :626-630